Search results
Showing 4096 to 4110 of 9009 results
NICE technology appraisal and highly specialised technologies guidance: the manual (PMG36)
This guide describes the methods and processes, including expected timescales, that NICE follows when carrying out health technology evaluations. The methods and processes are designed to produce robust guidance for the NHS in an open, transparent and timely way, with appropriate contribution from stakeholders. Organisations invited to contribute to health technology evaluation development should read this manual in conjunction with the NICE health technology evaluation topic selection: the manual. All documents are available on the NICE website
Making a positive impact: people and communities network case studies
Making a positive impact: NICE people and communities network case studies
Evidence-based recommendations on transvenous embolisation for spontaneous intracranial hypotension caused by a cerebrospinal fluid–venous fistula. This involves inserting a catheter through the femoral vein and injecting embolisation liquid to seal the fistula.
Show all sections
We offer a dedicated training opportunity towards achieving competency in either Faculty of Public Health Specialty Training curriculum outcomes.
Home Get involved Help develop quality standards...
Home News Blogs...
NICE's decisions on how we prioritise topics, by year.
Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.
Use this form to register your interest for a place on the HTA training programme debrief session.
Help us improve NICE: take part in research to help us develop better products and services.
Home Get involved...
Join NICE's people and communities network
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,
Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.